Literature DB >> 12033999

The management of pain in spasticity.

A B Ward1, M Kadies.   

Abstract

Pain is a common feature of spasticity and muscle spasms and the reasons for this are discussed in this article. However, the causes of this spasticity have to be determined and for successful management, knowing the underlying mechanisms, which produce spasticity, is necessary. In addition to knowing the range of available treatments, one has to know their particular contribution to the overall management of the patient. The assessment and management of the spastic patient is multi-disciplinary and painful spasticity changes over time. This therefore requires repeated assessments and the direction of the treatment may also change. Pain may be a dominant feature, but is rarely the sole symptom. This article looks at a strategy for the overall management of the patient with the focus on managing pain.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12033999     DOI: 10.1080/09638280110108878

Source DB:  PubMed          Journal:  Disabil Rehabil        ISSN: 0963-8288            Impact factor:   3.033


  11 in total

Review 1.  Botulinum toxin in multiple sclerosis.

Authors:  Wolfgang H Jost
Journal:  J Neurol       Date:  2006-02       Impact factor: 4.849

Review 2.  Central nervous system delivery of large molecules: challenges and new frontiers for intrathecally administered therapeutics.

Authors:  Ryan G Soderquist; Melissa J Mahoney
Journal:  Expert Opin Drug Deliv       Date:  2010-03       Impact factor: 6.648

Review 3.  Evaluation and Management of SCI-Associated Pain.

Authors:  Michael Saulino; Justin F Averna
Journal:  Curr Pain Headache Rep       Date:  2016-09

4.  Hellenic Spinal Cord Section of the Hellenic Society of Physical and Rehabilitation Medicine National Congress 2019, "Healthy, and long living after SCI" Proceedings. 13th-15th December 2019, Vellideio, Thessaloniki, Greece.

Authors: 
Journal:  J Musculoskelet Neuronal Interact       Date:  2019-12-01       Impact factor: 2.041

Review 5.  Current management of pain associated with multiple sclerosis.

Authors:  Walter Pöllmann; Wolfgang Feneberg
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

6.  Baclofen, a GABABR agonist, ameliorates immune-complex mediated acute lung injury by modulating pro-inflammatory mediators.

Authors:  Shunying Jin; Michael L Merchant; Jeffrey D Ritzenthaler; Kenneth R McLeish; Eleanor D Lederer; Edilson Torres-Gonzalez; Mostafa Fraig; Michelle T Barati; Alex B Lentsch; Jesse Roman; Jon B Klein; Madhavi J Rane
Journal:  PLoS One       Date:  2015-04-07       Impact factor: 3.240

7.  Functional stretching exercise submitted for spastic diplegic children: a randomized control study.

Authors:  Mohamed Ali Elshafey; Adel Abd-Elaziem; Rana Elmarzouki Gouda
Journal:  Rehabil Res Pract       Date:  2014-07-20

Review 8.  Pathophysiology of spasticity: implications for neurorehabilitation.

Authors:  Carlo Trompetto; Lucio Marinelli; Laura Mori; Elisa Pelosin; Antonio Currà; Luigi Molfetta; Giovanni Abbruzzese
Journal:  Biomed Res Int       Date:  2014-10-30       Impact factor: 3.411

9.  Baclofen Protects Primary Rat Retinal Ganglion Cells from Chemical Hypoxia-Induced Apoptosis Through the Akt and PERK Pathways.

Authors:  Pingping Fu; Qiang Wu; Jianyan Hu; Tingting Li; Fengjuan Gao
Journal:  Front Cell Neurosci       Date:  2016-11-04       Impact factor: 5.505

10.  INTRAPEC Technique Controls Pectoralis Spasm and Pain for Subpectoral Breast Implantation: A Retrospective Study.

Authors:  Jonathan Kline; Wayne Lee; Ken Wofford
Journal:  Plast Reconstr Surg Glob Open       Date:  2020-02-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.